Cointime

Joyn Bio

company

About

A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.

  • 11 - 50

Highlights

Total Funding Amount
$200M
Funding Rounds
2
Investors
1
Investments
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$100M
Industries
Agriculture,Biotechnology,Environmental Consulting,Health Care
Founded date
Sep 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Joyn Bio is a joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants to provide growers with next generation solutions to their biggest challenges. Joyn Bio’s first area of focus will be on engineering microbes that provide cereal crops with their nitrogen needs to reduce agriculture’s reliance on nitrogen fertilizer and its environmental impact. Joyn Bio brings together microbiologists, synthetic biologists, plant scientists, and ecologists at its headquarters in Boston, Massachusetts and its plant research facility in West Sacramento, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$200M
Joyn Bio has raised a total of $200M in funding over 2 rounds. Their latest funding was raised on Mar 20, 2018 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 20, 2018 Series A $100M 1 — — Detail
Sep 14, 2017 Series A $100M 1 — — Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Joyn Bio has made 1 investments. Their most recent investment was on Apr 19, 2022, when Flippy raised $1.15M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 19, 2022 Flippy
Seed $1.15M Cryptocurrency —

Investors

Number of Lead Investors
Number of Investors
—
1
Joyn Bio is funded by 1 investors. Bayer are the most recent investors.
Investor Name Lead Investor Funding Round
Bayer — Series A
Cointime
Chủ Đề
Công Ty